{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:37:50Z","timestamp":1792683470070,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.yebeh.2024.109782","type":"journal-article","created":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T00:27:49Z","timestamp":1713400069000},"page":"109782","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Evaluating the prevalence and risk factors for depression in patients with temporal lobe epilepsy with hippocampal sclerosis: A cross-sectional multicenter study"],"prefix":"10.1016","volume":"154","author":[{"given":"Bandar N.","family":"Aljafen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4866-8922","authenticated-orcid":false,"given":"Ruwa","family":"Alneseyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3044-641X","authenticated-orcid":false,"given":"Taim","family":"Muayqil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mashael O.","family":"Alkhateeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mubarak M.","family":"Aldosari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Alsermani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lujain","family":"Alnakhli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renad","family":"Althomali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razan","family":"Alnami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruba","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lama","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2197-5144","authenticated-orcid":false,"given":"Fawzi","family":"Babtain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2024.109782_b0005","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1017\/S0033291717003336","article-title":"Socio-economic variations in the mental health treatment gap for people with anxiety, mood, and substance use disorders: results from the WHO world mental health (WMH) surveys","volume":"48","author":"Evans-Lacko","year":"2018","journal-title":"Psychol Med"},{"key":"10.1016\/j.yebeh.2024.109782_b0010","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1053\/j.sult.2007.09.005","article-title":"MR imaging of temporal lobe epilepsy","volume":"28","author":"Camacho","year":"2007","journal-title":"Semin Ultrasound CT MR"},{"key":"10.1016\/j.yebeh.2024.109782_b0015","first-page":"13","article-title":"Current trends and hotspots in drug-resistant epilepsy research: insights from a bibliometric analysis","author":"Ni","year":"2022","journal-title":"Front Neurol"},{"key":"10.1016\/j.yebeh.2024.109782_b0020","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/epi.12220","article-title":"International consensus classification of hippocampal sclerosis in temporal lobe epilepsy: a task force report from the ILAE commission on diagnostic methods","volume":"54","author":"Bl\u00fcmcke","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2024.109782_b0025","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1590\/S0004-282X2013000300011","article-title":"Depression and temporal lobe epilepsy represent an epiphenomenon sharing similar neural networks: clinical and brain structural evidences","volume":"71","author":"Valente","year":"2013","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.yebeh.2024.109782_b0030","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.yebeh.2017.09.014","article-title":"Epilepsy as a network Disorder (1): what can we learn from other network disorders such as autistic spectrum disorder and mood disorders?","volume":"77","author":"Kanner","year":"2017","journal-title":"Epilepsy Behav EB"},{"key":"10.1016\/j.yebeh.2024.109782_b0035","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/epi.13781","article-title":"Concurrent mood and anxiety disorders are associated with pharmacoresistant seizures in patients with MTLE","volume":"58","author":"Nogueira","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2024.109782_b0040","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1590\/S0004-282X2011000200003","article-title":"Prevalence of psychiatric comorbidities in temporal lobe epilepsy in a southern brazilian population","volume":"69","author":"Bragatti","year":"2011","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.yebeh.2024.109782_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2021.108243","article-title":"Individuals who develop drug-resistant epilepsy within a year after initial diagnosis have higher burden of mental and physical diseases one-year prior to epilepsy diagnosis as compared to those whose seizures were controlled during the same interval","volume":"123","author":"Teneralli","year":"2021","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2024.109782_b0050","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0006-3223(03)00469-4","article-title":"Depression in epilepsy: prevalence, clinical semiology, pathogenic mechanisms, and treatment","volume":"54","author":"Kanner","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.yebeh.2024.109782_b0055","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.yebeh.2005.04.012","article-title":"Psychiatric comorbidity in epilepsy","volume":"7","author":"Swinkels","year":"2005","journal-title":"Epilepsy Behav EB"},{"key":"10.1016\/j.yebeh.2024.109782_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2023.109179","article-title":"The impact of epilepsy on quality of life: findings from a european survey","volume":"142","author":"Strzelczyk","year":"2023","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2024.109782_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2023.107084","article-title":"Quality of life and functional limitations in persons with epilepsy","volume":"190","author":"Karakis","year":"2023","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2024.109782_b0070","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12962-021-00304-5","article-title":"Cost-effectiveness of a care manager collaborative care programme for patients with depression in primary care: 12-month economic evaluation of a pragmatic randomised controlled trial","volume":"19","author":"Holst","year":"2021","journal-title":"Cost Eff Resour Alloc CE"},{"key":"10.1016\/j.yebeh.2024.109782_b0075","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/08039488.2019.1584240","article-title":"Psychiatric diagnosis in primary care patients with increased depressive symptoms","volume":"73","author":"Kotiaho","year":"2019","journal-title":"Nord J Psychiatry"},{"key":"10.1016\/j.yebeh.2024.109782_b0080","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S1474-4422(06)70415-X","article-title":"Rapid detection of major depression in epilepsy: a multicentre study","volume":"5","author":"Gilliam","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2024.109782_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2022.114531","article-title":"Association between epilepsy and risk of depression: a meta-analysis","volume":"312","author":"Chu","year":"2022","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.yebeh.2024.109782_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2023.120766","article-title":"Drug-resistant epilepsy: definition, pathophysiology, and management","volume":"452","author":"Mesraoua","year":"2023","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.yebeh.2024.109782_b0095","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1124\/pr.120.019539","article-title":"Drug resistance in epilepsy: clinical impact, potential mechanisms, and new innovative treatment options","volume":"72","author":"L\u00f6scher","year":"2020","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.yebeh.2024.109782_b0100","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.yebeh.2014.01.002","article-title":"The use of the NDDI-E in arabic to identify symptoms of depression of moderate or greater severity in people with epilepsy","volume":"32","author":"Alkhamees","year":"2014","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2024.109782_b0105","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/00031305.2016.1154108","article-title":"The ASA statement on p-values: context, process, and purpose","volume":"70","author":"Wasserstein","year":"2016","journal-title":"Am Stat"},{"key":"10.1016\/j.yebeh.2024.109782_b0110","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.yebeh.2016.09.035","article-title":"Major depressive episode, cognition, and epilepsy","volume":"64","author":"Tedrus","year":"2016","journal-title":"Epilepsy Behav EB"},{"key":"10.1016\/j.yebeh.2024.109782_b0115","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.yebeh.2012.06.015","article-title":"Screening for major depressive episodes in japanese patients with epilepsy: validation and translation of the japanese version of neurological Disorders depression inventory for epilepsy (NDDI-E)","volume":"25","author":"Tadokoro","year":"2012","journal-title":"Epilepsy Behav EB"},{"key":"10.1016\/j.yebeh.2024.109782_b0120","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.yebeh.2012.06.037","article-title":"Predictors of quality of life in patients with refractory mesial temporal lobe epilepsy","volume":"25","author":"Pauli","year":"2012","journal-title":"Epilepsy Behav EB"},{"key":"10.1016\/j.yebeh.2024.109782_b0125","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1111\/j.1528-1167.2011.03213.x","article-title":"Predictors of health-related quality of life and costs in adults with epilepsy: a systematic review","volume":"52","author":"Taylor","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2024.109782_b0130","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.yebeh.2010.08.012","article-title":"Neuroimaging changes in mesial temporal lobe epilepsy are magnified in the presence of depression","volume":"19","author":"Salgado","year":"2010","journal-title":"Epilepsy Behav EB"},{"key":"10.1016\/j.yebeh.2024.109782_b0135","doi-asserted-by":"crossref","unstructured":"Marinho AM da N, Lob\u00e3o-Soares B, Targino HAS, Vasconcellos YJF, Guarnieri R, Carlotti CG. Decreased hippocampal serotonin 5HT1A expression in mesial temporal lobe of epilepsy patients. Epilepsy Behav 2022;129:108574. Doi: 10.1016\/j.yebeh.2022.108574.","DOI":"10.1016\/j.yebeh.2022.108574"},{"key":"10.1016\/j.yebeh.2024.109782_b0140","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.seizure.2009.03.001","article-title":"Identifying depression in epilepsy in a busy clinical setting is enhanced with systematic screening","volume":"18","author":"Friedman","year":"2009","journal-title":"Seizure - Eur J Epilepsy"},{"key":"10.1016\/j.yebeh.2024.109782_b0145","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.0013-9580.2004.47003.x","article-title":"The relative impact of anxiety, depression, and clinical seizure features on health-related quality of life in epilepsy","volume":"45","author":"Johnson","year":"2004","journal-title":"Epilepsia"},{"issue":"Suppl 3","key":"10.1016\/j.yebeh.2024.109782_b0150","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.yebeh.2003.08.019","article-title":"Rates and risk factors for suicide, suicidal ideation, and suicide attempts in chronic epilepsy","volume":"4","author":"Jones","year":"2003","journal-title":"Epilepsy Behav EB"},{"key":"10.1016\/j.yebeh.2024.109782_b0155","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1111\/j.1528-1167.2007.01254.x","article-title":"Are depression and cognitive performance related in temporal lobe epilepsy?","volume":"48","author":"Tracy","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2024.109782_b0160","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.yebeh.2014.09.025","article-title":"Effects of psychosocial functioning, depression, seizure frequency, and employment on quality of life in patients with epilepsy","volume":"41","author":"Azuma","year":"2014","journal-title":"Epilepsy Behav EB"},{"key":"10.1016\/j.yebeh.2024.109782_b0165","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.yebeh.2005.09.014","article-title":"The presence and clinical implications of depression in a community population of adults with epilepsy","volume":"8","author":"Mensah","year":"2006","journal-title":"Epilepsy Behav EB"},{"key":"10.1016\/j.yebeh.2024.109782_b0170","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/epi.12913","article-title":"Quality-of-life outcomes of initiating treatment with standard and newer antiepileptic drugs in adults with new-onset epilepsy: findings from the SANAD trial","volume":"56","author":"Jacoby","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2024.109782_b0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2009.10.033","article-title":"Valproate for the treatment of acute bipolar depression: systematic review and meta-analysis","volume":"122","author":"Smith","year":"2010","journal-title":"J Affect Disord"},{"key":"10.1016\/j.yebeh.2024.109782_b0180","doi-asserted-by":"crossref","first-page":"935","DOI":"10.2174\/1570159X21666230224102318","article-title":"Pharmacological strategies for Bipolar Disorders in acute phases and chronic Management with a special focus on lithium, valproic acid, and atypical antipsychotics","volume":"21","author":"Carli","year":"2023","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.yebeh.2024.109782_b0185","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.yebeh.2006.09.008","article-title":"Effect of lamotrigine on depressive symptoms in adult patients with epilepsy","volume":"10","author":"Ettinger","year":"2007","journal-title":"Epilepsy Behav EB"},{"key":"10.1016\/j.yebeh.2024.109782_b0190","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41380-018-0044-2","article-title":"Pharmacological treatment of adult bipolar disorder","volume":"24","author":"Baldessarini","year":"2019","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.yebeh.2024.109782_b0195","first-page":"13","article-title":"Comparison of Lamotrigine and Oxcarbazepine monotherapy among chinese adult patients with newly-diagnosed focal-onset epilepsy: a prospective observational study","author":"Chen","year":"2022","journal-title":"Front Neurol"},{"key":"10.1016\/j.yebeh.2024.109782_b0200","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.yebeh.2008.05.012","article-title":"Positive and negative psychotropic effects of levetiracetam","volume":"13","author":"Helmstaedter","year":"2008","journal-title":"Epilepsy Behav EB"},{"key":"10.1016\/j.yebeh.2024.109782_b0205","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1159\/000520457","article-title":"Levetiracetam as an adjunctive treatment for mania: a double-blind, randomized","volume":"81","author":"Keshavarzi","year":"2022","journal-title":"Placebo-Controlled Trial Neuropsychobiology"},{"key":"10.1016\/j.yebeh.2024.109782_b0210","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/jhg.2017.91","article-title":"The pharmacogenomics of valproic acid","volume":"62","author":"Zhu","year":"2017","journal-title":"J Hum Genet"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152550502400163X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152550502400163X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T00:38:21Z","timestamp":1714783101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152550502400163X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":42,"alternative-id":["S152550502400163X"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2024.109782","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the prevalence and risk factors for depression in patients with temporal lobe epilepsy with hippocampal sclerosis: A cross-sectional multicenter study","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2024.109782","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109782"}}